Including 15 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider buying
Traded Nov 17 · filed 2 days later
Since the trade −6.7% · S&P 500 −2.3% · to Nov 19
Bought at the 52-week low, RSI 21, 60% under its 200-day average, 55 points behind the S&P 500 over 3 months
A major shareholder of Insight Molecular Diagnostics paid $6M out of pocket for Insight Molecular Diagnostics shares. It was the first purchase in 7 months. Shares held went up 27% with this purchase.
Insider filing
Traded Jul 1 · filed 6 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Jul 1 · filed 6 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Jul 1 · filed 6 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Jun 11 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 11 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 11 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Apr 23 – Apr 27, 2026 · largest single transaction ~$982K
Traded Apr 16 – Apr 20, 2026 · largest single transaction ~$352K
Traded Mar 26, 2026 · largest single transaction 6,289
Traded Mar 26, 2026 · largest single transaction 28K
Traded Mar 26, 2026 · largest single transaction 47K
Insider filing
Traded Mar 26 · filed 4 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Mar 26 · filed 4 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Mar 26 · filed 4 days later
Routine share withholding; mechanical by default.
Insider buying
First insider buy since Feb 2025Traded Feb 10 · filed 3 days later
Since the trade −77.6% · S&P 500 +3.4% · to Nov 19
A major shareholder of Insight Molecular Diagnostics paid $3M out of pocket for Insight Molecular Diagnostics shares.
Insider buying
Traded Feb 7, 2025 · filed 5 days later
The CFO of Insight Molecular Diagnostics paid $200K out of pocket for Insight Molecular Diagnostics shares. 2 other people at Insight Molecular Diagnostics bought some too, in the same month. Shares held went up 182% with this purchase.
Traded Feb 6, 2025 · largest single transaction ~$9.24M
Insider buying
Traded Feb 7, 2025 · filed 4 days later
A major shareholder of Insight Molecular Diagnostics paid $2.21M out of pocket for Insight Molecular Diagnostics shares. 2 other people at Insight Molecular Diagnostics bought some too, in the same month. Shares held went up 60% with this purchase.
Traded Jan 31 – Feb 4, 2025 · largest single transaction ~$1.8K
Traded Jan 29 – Jan 30, 2025 · largest single transaction ~$7.8K
Traded Jan 13 – Jan 14, 2025 · largest single transaction ~$22K
Insider buying
Traded Dec 26, 2024 · filed 2 days later
A major shareholder of Insight Molecular Diagnostics paid $192K out of pocket for Insight Molecular Diagnostics shares. 2 other people at Insight Molecular Diagnostics bought some too, in the same month. Shares held went up 5% with this purchase.
Insider buying
Traded Dec 26, 2024 · filed the same day
An Insight Molecular Diagnostics director paid $26K out of pocket for Insight Molecular Diagnostics shares. 2 other people at Insight Molecular Diagnostics bought some too, in the same month. Shares held went up 18% with this purchase.
Insider buying
Traded Dec 5, 2024 · filed 4 days later
The CFO of Insight Molecular Diagnostics paid $46K out of pocket for Insight Molecular Diagnostics shares. 2 other people at Insight Molecular Diagnostics bought some too, in the same month. Shares held went up 59% with this purchase.
Insider buying
Traded Oct 2, 2024 · filed 2 days later
A major shareholder of Insight Molecular Diagnostics paid $3.88M out of pocket for Insight Molecular Diagnostics shares. 1 other person at Insight Molecular Diagnostics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Oct 2, 2024 · filed 2 days later
The CFO of Insight Molecular Diagnostics paid $100K out of pocket for Insight Molecular Diagnostics shares. 1 other person at Insight Molecular Diagnostics bought some too, in the same month. It was the first purchase in over a year.